{"schema_version":"secwatch.filing_event.v1","accession":"0002023658-25-000082","form_type":"8-K","ticker":"BCAX","cik":"0002023658","company_name":"Bicara Therapeutics Inc.","filed_at":"2025-06-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.698206+00:00","generated_at":"2026-05-19T11:37:08.446830+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Bicara Therapeutics shareholders elect three Class I directors, ratify KPMG","bullets":["Elected Kiran Mazumdar-Shaw, Jake Simson, and Ryan Cohlhepp as Class I directors for three-year terms.","Vote results: Mazumdar-Shaw 30.8M for, 14.4M withheld; Simson 37.6M for, 7.6M withheld; Cohlhepp 44.8M for, 0.4M withheld.","Broker non-votes of approximately 2.6M shares on each director election.","Ratification of KPMG as auditor for FY2025 passed with 47.7M for, 7.8K against, 3.3K abstain."],"urls":{"canonical":"https://secwatch.observer/filing/0002023658-25-000082","json":"https://secwatch.observer/filing/0002023658-25-000082.json","markdown":"https://secwatch.observer/filing/0002023658-25-000082.md","text":"https://secwatch.observer/filing/0002023658-25-000082.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2023658/000202365825000082/0002023658-25-000082-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2023658/000202365825000082/bcax-20250609.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T11:37:08.446830+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}